Fig. 8 | Signal Transduction and Targeted Therapy

Fig. 8

From: Targeting epigenetic and posttranslational modifications regulating ferroptosis for the treatment of diseases

Fig. 8

Epigenetic and posttranslational modification of ferroptosis in Liver diseases and Lung diseases. AUF1 AU-rich element (ARE)-binding factor 1, BRD7 bromodomain-containing protein 7, COPD chronic obstructive pulmonary disease, GCN5L1 mitochondrial general control of amino acid synthesis 5 like 1, IRI ischemia/reperfusion injury, LOXs lipoxygenases, NETs neutrophil extracellular traps, Ptgs2 prostaglandin-endoperoxide synthase 2, STAT3 signal transducer and activator of transcription 3, TfR1 transferrin receptor 1, TMEM16A transmembrane member 16A, TMEM16A transmembrane member 16A

Back to article page